Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival

This retrospective study included 1030 patients with clear cell renal cell carcinoma (ccRCC) who underwent radical or partial nephrectomy at Wuhan Union Hospital from 2014 to 2023.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ccRCC

Sex eligibility

All sexes

Study type

Observational

Primary location

Wuhan Union Hospital

Wuhan, Hubei, 430000, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

primary clear cell renal cell carcinoma confirmed by histopathology;
patients≥18 years;
availability of preoperative abdominal computed tomography (CT) data;
patients with partial or radical nephrectomy.

Treatment and study plan

Primary outcomes

overall survival (OS)

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2023
Study completion: 2023
First posted: Jan 24, 2025
Registry last updated: Jan 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed